Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amgen Inc (NASDAQ:AMGN)

172.03
Delayed Data
As of 4:14pm ET
 +0.75 / +0.44%
Today’s Change
130.09
Today|||52-Week Range
181.81
+5.98%
Year-to-Date
Top 7 Research Reports for July 29, 2016
1:53pm / Zacks.com - Paid Partner Content
Biotech Earnings Battle: Gilead (GILD) vs. Amgen (AMGN)
Jul 25 / Zacks.com - Paid Partner Content
Company News for July 29, 2016
10:52am / Zacks.com - Paid Partner Content
3 Top Biotech Stocks to Buy Now
Jul 25 / MotleyFool.com - Paid Partner Content
UCB (UCBJF) Posts 1H16 Results, Reaffirms 2016 Guidance
10:52am / Zacks.com - Paid Partner Content
Amgen (AMGN) Stock Down Ahead of Q2 Earnings Report
Jul 25 / TheStreet.com - Paid Partner Content
Amgen (AMGN) Stock Higher After Q2 Results, Raised Forecast
Jul 28 / TheStreet.com - Paid Partner Content
Bristol-Myers (BMY): Stock to Beat Earnings Again in Q2
Jul 25 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Facebook, Amgen, Whole Foods and Groupon
Jul 28 / Zacks.com - Paid Partner Content
Celgene (CELG) Q2 Earnings: Can the Stock Pull a Surprise?
Jul 25 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Biogen, Gilead, AbbVie, Amgen and Celgene
Jul 28 / Zacks.com - Paid Partner Content
I'm Bullish on Biotechs
Jul 25 / TheStreet.com - Paid Partner Content
Amgen (AMGN) Tops Q2 Earnings & Revenues, Raises View
Jul 28 / Zacks.com - Paid Partner Content
Zacks Industry Outlook Highlights: Bristol-Myers, Pfizer, Sanofi, Amgen and Biogen
Jul 25 / Zacks.com - Paid Partner Content
2 Large Cap Drug Stocks to Watch for Earnings: ABBV & MRK
Jul 28 / Zacks.com - Paid Partner Content
Glaxo (GSK) Q2 Earnings: Can the Stock Pull a Surprise?
Jul 25 / Zacks.com - Paid Partner Content
Facebook (FB) Owns Q2 Earnings on Huge Beat, Plus GRPN, GPRO and More
Jul 27 / Zacks.com - Paid Partner Content
Vertex (VRTX) to Report Q2 Earnings: Is a Surprise in Store?
Jul 25 / Zacks.com - Paid Partner Content
Dr. Michael Burry of 'The Big Short' Portfolio Review Shows Several Large Gains
Jul 27 / GuruFocus News - Paid Partner Content
Amgen (AMGN) May Beat Q2 Earnings: Will the Stock Gain?
Jul 25 / Zacks.com - Paid Partner Content
Dr. Michael Burry 2016 Portfolio Review Shows Several Large Gains
Jul 27 / GuruFocus News - Paid Partner Content
Pharma Industry Outlook: Fundamentals Remain Strong
Jul 22 / Zacks.com - Paid Partner Content
Market Ends Weak as Rate Hike Put Off: See You in September?
Jul 27 / TheStreet.com - Paid Partner Content
Gilead (GILD) Stock Likely to Beat This Earnings Season
Jul 21 / Zacks.com - Paid Partner Content
Amgen (AMGN) Stock Down in After-Hours Trading Despite Q2 Earnings Beat, Positive Gui...
Jul 27 / TheStreet.com - Paid Partner Content
Stock Market News for July 21, 2016
Jul 21 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: Biogen Q2 Results Impress, Gilead HCV Franchise Under Pressure
Jul 27 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Zafgen, Celgene, Amgen, AbbVie and Biogen
Jul 21 / Zacks.com - Paid Partner Content
3 Drugs Stocks Pushing Industry Growth
Jul 27 / TheStreet.com - Paid Partner Content
Eli Lilly (LLY) May Beat Q2 Earnings: Will the Stock Gain?
Jul 21 / Zacks.com - Paid Partner Content
Daniel Loeb's Third Point 2nd-Quarter 2016 Investor Letter
Jul 27 / GuruFocus News - Paid Partner Content
Biotech Stock Roundup: Celgene in Immuno-Oncology Deal, Zafgen Drops Lead Drug
Jul 20 / Zacks.com - Paid Partner Content
Amgen Still Has Many Ways to Win
Jul 27 / TheStreet.com - Paid Partner Content
Better Buy: Gilead Sciences Inc. vs. Amgen Inc.
Jul 20 / MotleyFool.com - Paid Partner Content
Amgen Inc: What to Watch in Q2 Earnings
Jul 26 / MotleyFool.com - Paid Partner Content
Valeant's (VRX) Brodalumab BLA Up for Review in the U.S.
Jul 18 / Zacks.com - Paid Partner Content
5 Drug Stocks' Earnings on Jul 27: AMGN, VRTX & More
Jul 26 / Zacks.com - Paid Partner Content
3 Drug Stocks to Report Earnings on Jul 19: JNJ, NVS, NEOG
Jul 18 / Zacks.com - Paid Partner Content
AbbVie (ABBV) Q2 Earnings: Will the Stock Pull a Surprise?
Jul 26 / Zacks.com - Paid Partner Content
Biotech dives into Sardinia gene pool for secret of long life
Jul 18 / FT.com - Paid Partner Content
Alexion (ALXN) Q2 Earnings: Stock Likely to Disappoint
Jul 26 / Zacks.com - Paid Partner Content
3 Biotech Stocks for Conservative Investors
Jul 17 / MotleyFool.com - Paid Partner Content
One Biotech Plays Red Light, Green Light With the FDA
Jul 26 / MotleyFool.com - Paid Partner Content
4 Rock-Solid, Cheap Biotech Stocks
Jul 16 / MotleyFool.com - Paid Partner Content
Merck (MRK) Q2 Earnings: Will the Stock Pull a Surprise?
Jul 26 / Zacks.com - Paid Partner Content
5 Figures to Look For When Johnson & Johnson Reports Its Second-Quarter Results
Jul 15 / MotleyFool.com - Paid Partner Content
ARIAD (ARIA) to Report Q2 Earnings: Will the Stock Surprise?
Jul 26 / Zacks.com - Paid Partner Content
Biosimilars set topple two of the world's biggest drug franchises
Jul 14 / FT.com - Paid Partner Content